Advertisement
Home Conference Coverage

Conference Coverage

Conference Coverage

ESMO 2020: Sotorasib Active in Patients with KRAS p.G12C Mutation –...

Editorial Team -
General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2020: CheckMate 9ER Provides New First-Line Treatment Option for Patients...

Peter Hofland, Ph.D -

Confirmatory Phase III ASCENT Study Shows Significant Improved Overall Survival in...

Danielle Garcia -
Triple negative breast cancer cells showing abnormal expression basal-like markers not found on normal breast epithelial cells. Cells are stained with cytokeratins 14 (green) and 19 (red). Photo courtesy: Bill Schmitt.

ESMO 2020: Sacituzumab Govitecan Significantly Extends Overall Survival in Patients with...

Editorial Team -

ESMO 2020: Durvalumab Demonstrates Sustained Overall Survival in Unresectable Stage III...

Editorial Team -

ESMO 2020: Study Shows Major Differences in Access to Cancer Drugs...

Danielle Garcia -

ESMO 2020: Olaparib Improves Median Time Without Disease Progression in BRCAm...

Danielle Garcia -

ESMO 2020: Encouraging Early-Stage Clinical Results with Sacituzumab Govitecan in Brain...

Editorial Team -
Thoughtful young women suffering from ovarian cancer.

ESMO 2020: Phase I Data of XMT-1536 Supports Continued Development in...

Editorial Team -

ESMO 2020: Phase III Exploratory Analyses AYBINTIO® and Reference Bevacizumab in...

Peter Hofland, Ph.D -
123...32Page 1 of 32

LATEST NEWS

© 2001 - 2020 Sunvalley Communication, LLC. All Rights Reserved.